Vera Therapeutics Inc Share Price

NASDAQ: VERA

Mid Cap

$24.21

+0.44

(+1.85%)

as on September 16, 2025 at 1:29 am IST

$₹

Vera Therapeutics Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$22.72
Day's Price Range
$24.74
$24.21
6.15%
Downside
2.19%
Upside
52 Week's Low
52 Week's High
$18.53
52-Week Price Range
$51.61
$24.21
23.46%
Downside
113.18%
Upside

Vera Therapeutics Inc share price movements today

Previous Close: $23.77
Open: $24.19
Volume: 1.3M
Day's Low - High: $22.72 - $24.74
52 Week Low - High: $18.53 - $51.61

Vera Therapeutics Inc Historical Returns

1 Month Return: + 10.35 %
3 Month Return: + 4.53 %
1 Year Return: -36.63 %
3 Year Return: + 11.23 %
5 Year Return: 0 %

Vera Therapeutics Inc Stock Fundamentals & Key Indicators

Check Vera Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-4.0709

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-235.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

790782800.00%

Vera Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vera Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Vera Therapeutics Inc	BUY	$1.5B	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Vera Therapeutics Inc Stock including INR - Dollar returns

The Vera Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Vera Therapeutics Inc investment value today

Current value as on today

₹69,528

Returns

₹30,472

(-30.47%)

Returns from Vera Therapeutics Inc Stock

₹35,457 (-35.46%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Vera Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Vera Therapeutics Inc. Average target price of $62.73

Vera Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Vera Therapeutics Inc.

What analysts predicted

61.41%UPSIDE

Target Price

$62.73

Current Price

$24.21

Analyzed by

16 Analysts

Target

$62.73

Vera Therapeutics Inc target price $62.73, a slight upside of 61.41% compared to current price of $24.21. According to 16 analysts rating.

Vera Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Vera Therapeutics Inc Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:63% versus previous 30 day period

Vera Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	-	0	0	-	-	-	-	0
Operating Income	-31	-21	-21	-27	-31	-37	-49	-48	-57	-80
EBITDA	-29	-19	-21	-27	-27	-31	-44	-41	-57	-74
Interest Expense	0	0	0	1	1	1	1	1	1	1
Depreciation	0	0	-1	-1	-1	1	0	0	0	0
Income Before Tax	-30	-20	-20	-25	-28	-33	-46	-43	-51	-76
Income Tax Expense	0	2	1	0	0	-	-	0	-	-
Net Income	-29	-20	-20	-25	-28	-33	-46	-43	-51	-76
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Vera Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	1	-
Gross Profit	0	0	0	0	1	-
Operating Income	-11	-52	-34	-90	-102	-167
EBITDA	-11	-52	-34	-91	-102	-167
Interest Expense	0	0	0	0	3	7
Depreciation	0	0	0	0	-3	0
Income Before Tax	-11	-53	-32	-89	-95	-152
Income Tax Expense	0	0	0	0	0	0
Net Income	-11	-53	-32	-89	-95	-152
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-5155.21%	0.00%

Vera Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-20	-20	-25	-28	-33	-46	-43	-51	-76
Operating Cash Flow	-17	-22	-25	-33	-24	-36	-39	-54	-54
Investing Cash Flow	-86	16	18	-219	-22	38	-221	15	28
Financing Cash Flow	0	0	24	276	3	0	325	1	20
Change in Cash	-103	-6	18	23	-44	2	65	-37	-5

Vera Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-53	-32	-89	-95	-152
Operating Cash Flow	-34	-23	-67	-92	-134
Investing Cash Flow	0	-4	-70	-39	-425
Financing Cash Flow	85	53	101	133	606
Change in Cash	50	25	-36	1	46

Global Institutional Holdings in Vera Therapeutics Inc

Funds	Holdings
venBio Select Advisor LLC	8.93%
T. Rowe Price Associates, Inc.	7.45%
BlackRock Inc	6.26%
FMR Inc	5.06%
Vanguard Group Inc	4.57%

See all

Insights on Vera Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 113.0%
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.66% of holdings in Mar 2025 quarter
NO EFFECT
Against Peers
In the last 1 year, K P R Mill Ltd has given 16.3% return, outperforming this stock by 38.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 118.7% return, outperforming this stock by 105.1%
NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 31.34% of holdings in Mar 2025 quarter
NEGATIVE IMPACT
Price Dip
In the last 6 months, VERA stock has moved down by -3.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, VERA stock has moved down by -5.2%

About Vera Therapeutics Inc

trucode gene repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis. the elegance of triplex gene editing lies in its ability to harness natural, high-fidelity dna repair mechanisms, and its independence from the requirement for exogenous nucleases and viral vectors.

Organisation	Vera Therapeutics Inc
Headquarters	2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
Industry	Services
CEO	Dr. Marshall W. Fordyce M.D.
E-voting on shares	Click here to vote

Key Management of Vera Therapeutics Inc

Name	Title
Mr. Sean P. Grant M.B.A.	Chief Financial Officer
Mr. Joseph R. Young M.B.A.	Senior VP of Finance & Chief Accounting Officer
Dr. Allen Ebens B.Sc., Ph.D.	Executive Vice President of Research
Dr. Marshall W. Fordyce M.D.	Founder, President, CEO & Director
Mr. Jason S. Carter	Chief Legal Officer
Dr. Robert M. Brenner M.D.	Chief Medical Officer
Ms. Emma Haywood	Vice President of Marketing
Mr. David L. Johnson M.B.A.	Chief Opearating Officer
Ms. S. Sandra Park J.D.	Senior VP of Legal, Healthcare,Commercial Law, Compliance & Operations
Ms. Debra Charlesworth	Vice President of Corporate Communications

FAQs

What is Vera Therapeutics Inc share price today?

Vera Therapeutics Inc share price today is $24.21 as on September 16, 2025 at 1:29 am IST at the close of the market. Vera Therapeutics Inc share today touched a day high of $24.74 and a low of $22.72.

What is the 52 week high and 52 week low for Vera Therapeutics Inc share?

Vera Therapeutics Inc share touched a 52 week high of $51.61 on November 13, 2024 and a 52 week low of $18.53 on April 9, 2025. Vera Therapeutics Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $24.21,which is 53.09% down from its 52 week high and 30.65% up from its 52 week low.

What is Vera Therapeutics Inc's market capitalisation today?

Vera Therapeutics Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Vera Therapeutics Inc Stock (VERA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Vera Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vera Therapeutics Inc Shares that will get you 0.0620 shares as per Vera Therapeutics Inc share price of $24.21 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vera Therapeutics Inc Stock (VERA) from India?

Indian investors can start investing in Vera Therapeutics Inc (VERA) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 6:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Vera Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 6:38 am IST). Based on Vera Therapeutics Inc share’s latest price of $24.21 as on September 16, 2025 at 1:29 am IST, you will get 0.4131 shares of Vera Therapeutics Inc. Learn more about fractional shares .